awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26738860-DBD74A53-E14E-488A-A5F7-9DB8089F1A99
Q26738860-DBD74A53-E14E-488A-A5F7-9DB8089F1A99
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26738860-DBD74A53-E14E-488A-A5F7-9DB8089F1A99
Personalized Clinical Trials in Hepatocellular Carcinoma Based on Biomarker Selection
P2860
Q26738860-DBD74A53-E14E-488A-A5F7-9DB8089F1A99
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26738860-DBD74A53-E14E-488A-A5F7-9DB8089F1A99
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
15471861dcd348ad609956026aa0ecbf4761fd9a
P2860
Linifanib versus Sorafenib in patients with advanced hepatocellular carcinoma: results of a randomized phase III trial.